Is Oscar Heath’s IPO Flop a Buying Opportunity?

1 min read

Health insurer Oscar Health (NYSE:OSCR) has had a horrible debut on the public market, with shares trading substantially below the IPO price. Unfortunately, Oscar seems caught between a valuation based on its technology prospects and its core business as a health insurer, where the economics aren’t nearly as prosperous.

In this video from Motley Fool Live, recorded on March 8, contributors Brian Orelli and Keith Speights discuss Oscar’s potential and the considerations investors should take into account when valuing Oscar Health.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Fortinet Partners With Linksys to Secure Work-From-Home Employees

Next Story

3 Reasons Adobe Stock Is a Reopening Play

Latest from Blog